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The association between cigarette use and depression has been documented in many 
studies. Fewer studies have examined other tobacco products such as electronic cigarettes (e-
cigarettes) and hookah that are used by young adults. This study examined whether increased 
frequency of use of these products was associated with depressive symptoms in a cohort of 
n=5,236 Texas college students followed from 2014 to 2017. A hierarchical model showed 
that increased frequency of single product use of cigarettes, refillable e-cigarettes and hookah 
was associated with depressive symptoms. Refillable and disposable e-cigarettes were 
examined separately and results did not provide evidence of a different association for each 
type of e-cigarette when cigarettes were not also used. Dual use of cigarettes with another 
product was also examined. Dual use was associated with higher depressive symptoms for 
most product combinations. However, infrequent dual use of disposable e-cigarettes and 
cigarettes may not be associated with depressive symptoms. Suggestions for further research 
are included. 
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BACKGROUND 
Literature Review 
Cigarettes and Alternative Tobacco Products 
During the 20th century tobacco use was one of the most active areas of public health 
and among United States (U.S.) adults the prevalence of smoking decreased from 42.4% in 
1965 to 24.7% in 1997 (CDC, 1999). More recently, the 2016 National Health Interview 
Survey estimated the prevalence of current cigarette smoking among U.S. adults to be 15.5% 
(Jamal, 2018). Although cigarette use has declined, new types of tobacco products have 
emerged that are increasing in popularity, such as electronic cigarettes (e-cigarettes) and 
hookah (McMillen, Gottlieb, Shaefer, Winickoff, & Klein, 2015). The 2016 National Health 
Interview Survey estimated the prevalence of e-cigarettes as 15.3% for ever-use and 3.2% for 
current use (CDC, 2017). A study of 2014-2015 data estimated the prevalence of hookah 
smoking among U.S. adults as 15.8% for ever-use and 1.5% for past 30-day use (Majeed, 
Sterling, Weaver, Pechacek, & Eriksen, 2017). These products are more popular among 
young adults than older age groups (CDC, 2017; Majeed et al., 2017). Use of multiple 
tobacco products is common; approximately 40% of users used more than one product in 
2013-2014 (Kasza et al., 2017).  
Depression 
Depression is a leading cause of disease burden and, according to the 2010 Global 
Burden of Disease study, depressive disorders were the second highest contributor of years 
lived with disability (Ferrari et al., 2014). More than just a disabling condition, a 2015 meta-
analysis concluded that depression is associated with higher relative risk of all-cause 
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mortality (RR = 1.71) (Walker, McGee, & Druss, 2015). Past year prevalence of a self-
reported major depressive episode among U.S. adults was 6.7% overall in 2016 (Center for 
Behavioral Health Statistics and Quality, 2017). Among 18-25 year-olds, the prevalence was 
10.9%, compared with 7.4% among ages 26-49 and 4.8% among those 50 or older. This 
indicates that young adulthood is a key period in the life course for major depression. 
Cigarettes and Depression 
The association between cigarette use and depression has been well documented in 
many studies. A 2014 meta-analysis of 78 cross-sectional studies reports a statistically 
significant association between cigarette use and depression (OR = 1.5) (Luger, Suls, & 
Vander Weg, 2014). A number of hypotheses have been proposed to explain the association 
between cigarette use and depression including: (1) the self-medication hypothesis, that 
individuals who experience mental distress smoke to relieve negative affect (Audrain-
McGovern, Rodriguez, & Kassel, 2009), (2) that smoking causes depression, possibly 
because of prolonged nicotine exposure (Boden, Fergusson, & Horwood, 2010; Markou, 
Kosten, & Koob, 1998), (3) that the relationship is bi-directional (Leung, Gartner, Hall, 
Lucke, & Dobson, 2012) or (4) that the association is not causal and may be due to common 
risk factors or unobserved residual confounding (Kendler et al., 1993). A recent systematic 
review was inconclusive regarding which of these hypotheses had the strongest support from 
the literature and called for more research using sophisticated methods for causal inference 
(Fluharty, Taylor, Grabski, & Munafò, 2017). 
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Alternative Tobacco Products and Depressive Symptoms  
To the best of our knowledge only ten studies to date have investigated the 
association between e-cigarette or hookah use and depressive symptoms. Six of the ten 
studies examined e-cigarettes (Bandiera, Loukas, Wilkinson, & Perry, 2016; Bandiera, 
Loukas, Xiaoyin, Wilkinson, & Perry, 2017; Cummins, Zhu, Tedeschi, Gamst, & Myers, 
2014; King, Reboussin, Spangler, Cornacchione Ross, & Sutfin, 2018; Lechner, Janssen, 
Kahler, Audrain-McGovern, & Leventhal, 2017; Leventhal et al., 2016) and six of the ten 
studies examined hookah (Bandiera et al., 2016; Fielder, Carey, & Carey, 2012; Goodwin et 
al., 2014; Heinz et al., 2013; King et al., 2018; Primack, Land, Fan, Kim, & Rosen, 2013). 
The association between e-cigarettes and depressive symptoms is a consistent research 
finding in all six studies but the directionality of the association remains unclear. Bandiera et 
al. (2017) used a cross lagged model with data from the Marketing and Promotions across 
Colleges in Texas project and found that depressive symptoms significantly predicted 
subsequent e-cigarette use six months later, but e-cigarette use did not significantly predict 
subsequent depressive symptoms. Lechner et al. (2017), a study of adolescents, reported a bi-
directional association based on past 6-month use. Lechner used separate models to show that 
1) depressive symptoms among never-users were prospectively associated with subsequent 
initiation of e-cigarettes and 2) use of e-cigarettes at both waves 2 and 3 was associated with 
a higher growth rate in depressive symptoms. In the second model, e-cigarette use, the 
independent variable, was measured at waves 2 and 3, and did not temporally precede the 
measurements for depressive symptoms. In fact, a possible explanation of Lechner’s results 
for this second model is that adolescents with increasing depressive symptoms were more 
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likely to sustain e-cigarette use from wave 2 to wave 3. Although Lechner’s results are 
interesting, that paper does not discuss that possibility, nor does it give any defense for using 
separate models instead of a cross-lagged model to assess bi-directionality. Lechner was also 
the only study to examine frequency or intensity of use and depressive symptoms but only 
measured frequency of e-cigarette use at one time point. None of these studies used repeated 
measures of frequency of individuals’ e-cigarette use at multiple time points. These studies 
relied on between-person comparisons and could not compare the same individual’s 
depressive symptoms when that individual was using tobacco more frequently versus less 
frequently (or not at all). These designs also have less statistical power than a repeated 
measures study with the same number of participants (Lu et al., 2013). Additionally, 
although a suggestion for further research in the Lechner discussion, none of these studies 
distinguished between types of e-cigarettes (e.g. refillable and disposable). 
 Past studies of the association between hookah use and depressive symptoms have 
been somewhat inconclusive. Most studies did not report an association between hookah use 
and depressive symptoms, however the largest study with n=100,891 participants did find an 
association (Primack et al., 2013) and the most recent study reported a marginally significant 
association (p = .052) (King et al., 2018). All of the studies on hookah use and depressive 
symptoms have been cross-sectional except for Fielder et al. (2012). Fielder only used 
depressive symptoms as measured at baseline in a sample of women. Again, none of these 
studies used repeated measures of individuals’ frequency of hookah use or depressive 
symptoms at multiple time points, eliminating the possibility of within-person comparisons.  
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Cigars and smokeless tobacco were not found to be significantly associated with 
depressive symptoms by King et al. (2018) or Bandiera et al. (2016). Cigars and smokeless 
tobacco are less commonly used than other products (e.g. cigarettes, e-cigarettes and hookah) 
and King suggested the lack of significant findings for these products may be due to small 
sample size. 
The association between use of multiple products and depressive symptoms was 
examined in only two of these studies (Lechner et al., 2017; Leventhal et al., 2016). Both 
studies examined dual use of e-cigarettes and cigarettes in adolescents. Lechner et al. 
measured past 6-month use and found that dual use was associated with significantly higher 
depressive symptoms compared with non-use, but dual use was not significantly different 
from single product use with respect to depressive symptoms. Leventhal et al. measured 
ever-use and found that n=189 adolescent dual users had lower depressive symptoms than 
n=152 cigarette users, but higher depressive symptoms than n=412 e-cigarette users. None of 
these studies have examined dual use and depressive symptoms in young adults, nor have 
they examined other product combinations such as dual use of hookah and cigarettes. Again, 
none of these studies differentiated between types of e-cigarette. 
 To measure depressive symptoms, most studies of alternative tobacco product use 
rely on questionnaires such as the Center for Epidemiologic Studies Depression 10 Scale 
(CES-D-10) or Patient Health Questionnaire (PHQ-9) rather than a clinical diagnosis. One 
exception is Cummins et al. (2014) who asked participants if they had been diagnosed with a 
mental health condition. Validation studies suggest that measures from questionnaires are 
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correlated with traditional diagnostic interviews and have acceptable sensitivity and 
specificity (Shean & Baldwin, 2008). 
Public Health Significance 
Given the increasing prevalence of alternative tobacco product use and the high 
disease burden of depression, their association merits further study. The relationship between 
alternative tobacco product use and depressive symptoms is not well understood. To the best 
of my knowledge this would be the first study to use repeated measures of the frequency of 
alternative tobacco product use to examine the association between frequency of use and 
depressive symptoms. It also would be the first study of depressive symptoms to analyze 
disposable and refillable e-cigarettes separately. Young adulthood, the focus of this study, is 
a key period in the life course for tobacco product use and depressive symptoms. 
Furthermore, I claim that frequency of alternative tobacco product use is of intrinsic 
public health significance. It is plausible that the potentially harmful effects of alternative 
tobacco product use are positively associated with more frequent use. Dose-response is also 
part of the Bradford-Hill criteria, a framework that is commonly applied in epidemiology 
when examining associations that could be causal (Rothman & Greenland, 2005). Although 
the Bradford-Hill criteria were never intended as a checklist for establishing causality 
(Höfler, 2005), assessing the dose-response relationship between severity of depressive 
symptoms and frequency of alternative tobacco product use could contribute toward a deeper 
understanding of their association. 
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Specific Aims 
1) To measure the association between frequency of tobacco product use and depressive 
symptoms among young adults. Multiple tobacco products will be studied, including 
e-cigarettes and hookah, in addition to cigarettes. For each tobacco product, we 
hypothesize that more frequent use will be associated with increased depressive 
symptoms.  
2) To examine the association between types of e-cigarettes (i.e. refillable and 
disposable e-cigarettes) and depressive symptoms among young adults. 
3) To assess whether dual use of cigarettes with another tobacco product has a different 
association with depressive symptoms than use of either product alone. 
METHODS 
Data Set 
 Data came from the Marketing and Promotions across Colleges in Texas project (M-
PACT). M-PACT is a prospective cohort study of students from 24 colleges in Texas. M-
PACT began in October 2014 with follow up at six-month intervals through June 2017 for a 
total of six repeated measures. Retention rates ranged from 78-81%. 246 participants (4.5%) 
had missing data in every survey wave including baseline, leaving a sample of 5,236 
participants (95.5%) out of the original 5,482 participants. These 5,236 participants were 18-
29 years old at baseline (mean = 21.0; standard deviation (SD) = 2.3) and 36.7% male. Many 
participants were non-Hispanic white (37.3%) or Hispanic (30.9%); fewer participants were 
Asian (16.8%), Black (7.5%) or another race/ethnicity (7.5%). Only 7.1% of students 
attended a two-year college rather than a four-year institution. Almost half of students had 
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fathers with either a Bachelor’s degree (26.8%) or a graduate degree (20.8%). For more 
information about M-PACT see Loukas et al. (2016). 
Measures 
The following variables were considered in the analysis: 
Socio-demographic Covariates 
Sex, race/ethnicity and baseline age (standardized with mean=0 and SD=1) were 
considered. Since M-PACT lacks a direct measure of socio-economic status, father’s 
education level was considered as a proxy for socio-economic status. Father’s education level 
ranged from “No high school” to a “Graduate degree” (coded from 0-7 then standardized). 
Whether the participant attended a two-year or four-year college was also considered. 
Depressive Symptoms 
Depressive symptoms were measured with the Center for Epidemiologic Studies 
Depression 10 scale (CES-D-10), a 10-item measure (Andresen, Malmgren, Carter, & 
Patrick, 1994). Eight items asked about the frequency of a depressive symptom within the 
past 7 days and is scored from 0 “rarely (less than 1 day)” to 3 “most of the time (5-7 days).” 
Two items asked about the frequency of feeling hopeful or happy and were reverse coded. 
The scores were added to form a summary score with higher scores indicating a greater 
frequency of depressive symptoms. Cronbach’s alpha for the sample at baseline was 0.81, 
indicating good internal consistency. Depressive symptoms were modeled as the dependent 
variable over waves 1-6. 
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Product Use: Past 30 Day Use and Frequency of Use 
Past 30-day use of tobacco products was measured by the question, “During the past 
30 days, have you used [product]?” To ensure proper comprehension, the survey also 
included pictures of the type of tobacco product described in the question. Past 30 day use 
was a dichotomous measure (Yes/No coded as 1/0 respectively). To measure frequency of 
use, participants were asked, “On how many of the last 30 days have you used such a 
product?” For the final model, frequency of use was modeled per every 5 days; i.e. the 
number of days used (range: 0-30) was divided by 5 to create a scaled variable (range: 0-6) 
and each unit of the scaled variable represented 5 days of use in the past 30 days. Scaling can 
help model convergence (Cheng, Edwards, Maldonado-Molina, Komro, & Muller, 2010) and 
interpretation. Product use was modeled using independent variables over waves 1-6. 
Statistical Analysis 
Descriptive statistics were calculated to describe the sample (Table 1). The past 30-
day prevalence was calculated separately for each product. Participants could use more than 
one tobacco product in the past 30 days and product use was not described with mutually 
exclusive categories. The prevalence of past 30 day use of 2 or more products was also 
calculated. Frequency of use of each product was described among users of that product with 
the median and interquartile range (IQR). 
To examine the association between product use and depressive symptoms over 
waves 1-6, a hierarchical (also called “mixed” or “multi-level”) model was used. Hierarchical 
models may be the most widely used statistical method for analyzing repeated measures data 
(Gibbons, Hedeker, & DuToit, 2010). Depressive symptoms (CES-D-10) were modeled as 
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the dependent variable and product use as independent variables. This allows the association 
for each tobacco product to be estimated while adjusting for use of other products. CES-D-10 
score, a skewed variable, was modeled as a count variable measuring frequency of depressive 
symptoms with a Poisson likelihood and a canonical log link (for an example of a Poisson 
model for CES-D-10 score see Ranney et al., 2017). All models were adjusted for socio-
demographic covariates (race/ethnicity, sex, baseline age, two- vs. four-year college and 
father’s education) and survey wave (standardized with mean=0 and SD=1). Heterogeneity 
between individuals was modeled with a varying (“random”) intercept and slope for survey 
wave. Rate ratios (RR) were calculated using 𝑒𝛽 and represent the multiplicative change in 
depressive symptoms (CES-D-10) associated with a one unit increase in the independent 
variable. 
To select a model that fit the data well, multiple models were tried and then compared 
by Akaike’s Information Criterion (AIC). Some models used categorical variables for 
frequency of use (e.g. 0 days, 1-5 days or 6+ days) and other models used continuous 
variables (Specific Aim 1). Each model with continuous variables for frequency use also had 
dichotomous variables for past 30 day use. This ensures that conclusions drawn from the 
frequency of use variables are due to differences in depressive symptoms between more 
frequent use and less frequent (but non-zero) use and not simply because there is a difference 
between 0 days (non-use) and 1+ days. Refillable and disposable e-cigarettes were modeled 
as separate product types in all models (Specific Aim 2). Interaction terms were then added 
for dual use of cigarettes with refillable e-cigarettes, disposable e-cigarettes, hookah and 
cigars (i.e. the 8 interaction terms tried included past 30 day and frequency of use variables 
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for cigarettes x refillable e-cigarettes, cigarettes x disposable e-cigarettes, cigarettes x 
hookah, and cigarettes x cigars), but no interactions were tried for smokeless tobacco, the 
most rarely used product. Interaction terms allow for the possibility that dual use could have 
a different association than what would be expected from combining the associations for 
each of the two products (Specific Aim 3). AIC suggested a model with continuous 
frequency of use variables and four interaction terms (Table 2) provided the best fit to the 
data. One interaction term was marginally significant (p=.07) but was retained because it 
improved AIC. All results reported in the text are from that model but the overall conclusions 
are not highly sensitive to model choice.  
To ensure the robustness of conclusions, Bayesian models were also fit to the data 
with regularizing priors and Markov Chain Monte Carlo (MCMC) (Appendix A). The results 
from frequentist and Bayesian analyses were similar and most estimates were identical when 
rounded to the second decimal place. Model fit for frequentist and Bayesian models was 
checked graphically. 
To aid with model interpretation, examples of the estimated total association for 
product use after accounting for frequency of use, past 30 day use and relevant interactions 
are reported (Table 3). Missing data only affected 7.8% of observations (including 
incomplete observations from participants excluded from the study due to missing data). 
Hierarchical modeling is one of the most robust methods available for missing data in 
longitudinal studies (Gibbons et al., 2010). All analysis was conducted in R 2.5.1 (R Core 
Team, 2018) with the lme4 and brms packages (Bates, Mächler, Bolker, & Walker, 2015; 
Bürkner, 2017).  
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RESULTS 
Product Use Descriptive Statistics 
Cigarettes were the most common product used within the past 30 days and n=1,117 
(21.3%; Table 1) of participants used at baseline. When both types of e-cigarette were 
considered together, past 30 day prevalence of e-cigarettes (n=907; 17.3%; data not shown) 
was similar to hookah (n=885; 16.9%). After separating e-cigarette use by type, refillable e-
cigarettes were much more common (n=768; 14.7%) than disposable e-cigarettes (n=303; 
5.8%) at baseline. Past 30 day use of two or more products was relatively common (n=1,021; 
19.6%). Products were often used infrequently and the median days of use within the past 30 
days ranged from 2 to 5, indicating at least half of all users used each product 5 days or less 
(Table 1). 
Frequency of Use 
A hierarchical model of waves 1-6 showed that increased frequency of use was 
associated with increased depressive symptoms (CES-D-10) for cigarettes, refillable e-
cigarettes and hookah, the three most commonly used products. Every five days of use in the 
past 30 days was associated with 3% higher depressive symptoms for cigarettes (Rate Ratio 
(RR): 1.03; 95% CI: 1.02-1.04; p<.001; Table 2), 1% for refillable e-cigarettes (RR: 1.01; 
95% CI: 1.00-1.03; p=.02), and 3% for hookah (RR: 1.03; 95% CI: 1.01-1.05; p<.01). These 
estimates were for use of a single product (for dual use estimates see below and table 3). The 
frequency of use results for disposable e-cigarettes, cigars and smokeless tobacco were not 
statistically significant. However, results suggested that past 30 day use of smokeless tobacco 
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was associated with a 1.10 times higher (Rate Ratio) CES-D-10 score (95% CI: 1.04-1.16; 
p<.001) regardless of frequency of use. 
When a single product was used for 5 days in the past 30 days, estimates for the total 
effect of product use ranged from cigars (RR: 1.03 95% CI: 1.00-1.07; Table 3) to smokeless 
tobacco (RR: 1.10; 95% CI: 1.04-1.16). When a single product was used for 15 days in the 
past 30 days, estimates ranged from disposable e-cigarettes (RR: 1.05; 95% CI: 0.98-1.13) to 
cigarettes (RR: 1.13; 95% CI: 1.10-1.16). Hookah was associated with depressive symptoms 
with 5 days of use in the past 30 days (RR: 1.04; 95% CI: 1.01-1.06) and 15 days of use (RR: 
1.09; 95% CI: 1.04-1.15). 
E-cigarette Type 
Results did not provide evidence of a difference in the associations for refillable and 
disposable e-cigarettes when cigarettes were not also used. The 95% intervals for disposable 
e-cigarettes were wide enough to encompass both zero and the estimates for refillable e-
cigarettes. For example, the estimates for 5 days use of disposable e-cigarettes (RR: 1.05; 
95% CI: 0.99-1.11; Table 3) were similar to the estimates for 5 days use of refillable e-
cigarettes (RR: 1.04; 95% CI: 1.02-1.07).  
Dual Use 
When disposable e-cigarettes were used in conjunction with cigarettes, a significant 
interaction was observed. Results suggested that infrequent use of disposable e-cigarettes and 
cigarettes was not associated with depressive symptoms and 5 days of use of each product 
was not statistically significant (RR: 1.00; 95% CI: 0.96-1.05; Table 3).      
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Except for the disposable e-cigarette and cigarette interaction noted above, other 
interactions were small in magnitude (see table 2) and most estimates for dual product use 
were higher than single product use (see table 3). For example, the estimated total association 
for 5 days of cigarette use and 5 days of refillable e-cigarette use (RR: 1.11; 95% CI: 1.07-
1.14) was higher than the estimated association for 5 days of cigarette use (RR: 1.07; 95% 
CI: 1.04-1.09) and higher than the estimated association for 5 days of refillable e-cigarette 
use (RR: 1.04; 95% CI: 1.02-1.07). 
DISCUSSION 
 This study examines frequency of tobacco product use and depressive symptoms in a 
large cohort of young adults over a three-year period. Most previous studies of alternative 
tobacco products and depressive symptoms have examined product use without regard to 
frequency of use. Additionally, this study extends existing research by distinguishing 
between refillable and disposable e-cigarettes. Finally, the present study considers dual use of 
cigarettes with another tobacco product. 
 To the best of our knowledge, this is the first study to conclude that hookah frequency 
of use is associated with depressive symptoms. Previous studies have examined hookah 
without regard to frequency of use and only one large study found a significant association 
(Primack et al., 2013). This finding may not be very surprising since use of other products 
(e.g. cigarettes) are associated with depressive symptoms. Nevertheless, this is only the 
second study to report any kind of significant association between hookah and depressive 
symptoms. 
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Previous studies of e-cigarette use and depressive symptoms have found significant 
associations but this is one of the first studies to examine e-cigarette frequency of use 
specifically. Lechner et al. (2017), the only study to include frequency of use, found a 
positive association among adolescents, but did not distinguish between refillable and 
disposable e-cigarettes. The present study confirms this association for refillable e-cigarettes 
in a cohort of young adults with repeated measures data. However, due to wide confidence 
intervals for disposable e-cigarettes, this study is unable to come to firm conclusions 
regarding whether disposable e-cigarettes are positively associated or whether there are 
differences in the associations for disposable and refillable e-cigarettes when e-cigarettes 
were the only product used. It is true that refillable e-cigarettes have a significant association 
and disposable e-cigarettes do not have a significant association, however this does not imply 
a difference between these associations (Gelman & Stern, 2006) and the lack of significance 
for disposable e-cigarettes may be because fewer participants used them. 
Dual use was associated with higher depressive symptoms than single product use for 
most product combinations examined. However, this study suggests that infrequent dual use 
of cigarettes and disposable e-cigarettes is not associated with depressive symptoms. A 
possible explanation for this finding is that this specific type of use may be representative of 
experimental tobacco product use behavior, distinct from that of a more committed smoker. 
Two previous studies examining dual use and depressive symptoms had mixed results and 
were in adolescent populations (Lechner et al., 2017; Leventhal et al., 2016), whereas this 
study was in young adults. These studies did not use past 30 day use to measure product use. 
Also, these studies did not differentiate between disposable and refillable e-cigarettes.  
24 
 
A strength of this study is the use of repeated measures data in a large cohort. This 
provided enough data to estimate the associations for each product while adjusting for use of 
other products, which is important since many people use more than one product (Kasza et 
al., 2017). Most previous studies (e.g. King et al., 2018) estimated the association for each 
product separately. Bandiera et al. (2016) adjusted for other product use, but to our 
knowledge this is the first study to consider interaction effects between products. Smaller 
sample sizes or cross-sectional data may also explain the rarity of previous findings 
regarding hookah. 
One limitation is that data were collected at six-month intervals. If data were 
collected more frequently (e.g. monthly) it may be viable to determine the temporal 
relationship between product use and depressive symptoms. However, since most prior 
studies have been cross-sectional or used annual data, collecting data at six month intervals is 
an improvement on most contemporary tobacco use studies. Another limitation of this study 
is that nicotine content was not measured. Although it is possible to investigate whether 
frequency of use is associated with depressive symptoms, this study does not indicate 
whether the increase in depressive symptoms is caused by increased nicotine intake or if the 
increased frequency of use behavior is a byproduct of increased depressive symptoms. Future 
research investigating a dose-response relationship between nicotine and depressive 
symptoms may help support or disconfirm the hypothesis that nicotine causes depressive 
symptoms rather than the self-medication hypothesis. Also, the tobacco landscape is 
changing rapidly and this study used data from 2014 to 2017. Research on newer products 
(e.g. Juul) and depressive symptoms could be informative. Additionally, this study is limited 
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by a reliance on self-report data, which may be less accurate than objective measures (e.g. for 
frequency of use). Despite these limitations, this study adds to our knowledge about tobacco 
product use and provides strong evidence for its conclusions. 
CONCLUSION 
 Increased frequency of single product use of cigarettes, refillable e-cigarettes and 
hookah are associated with depressive symptoms. For single product use, there is no 
evidence to suggest a difference by e-cigarette type (refillable and disposable e-cigarettes) 
and depressive symptoms. Dual use is typically associated with higher depressive symptoms 
than single use, except when disposable e-cigarettes and cigarettes are both used 
infrequently. Future research on tobacco product use would be more informative if it 
included nuances such as frequency of use, type of e-cigarette and quantity of nicotine.   
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Table 1. Descriptive Statistics of Baseline Data (November 2014; n=5,236) 
Socio-demographics Mean SD 
Age 21.0 2.3 
 n % 
Male 1,919 36.7 
Race/Ethnicity   
White 1,953 37.3 
Hispanic 1,620 30.9 
Black 391 7.5 
Asian 881 16.8 
Other 391 7.5 
Two-year college (vs. four-year) 373 7.1 
Father’s education   
No high school 339 6.5 
Some high school 390 7.4 
Graduated high school 790 15.1 
Vocational/Technical school 208 4.0 
Some college 742 14.2 
Associate's degree 276 5.3 
Bachelor's degree 1,404 26.8 
Graduate degree 1,087 20.8 
Past 30 day use (non-exclusive) n % 
Cigarettes 1,117 21.3 
Refillable E-cigarettes 768 14.7 
Disposable E-cigarettes 303 5.8 
Hookah 885 16.9 
Cigars 512 9.8 
Smokeless 156 3.0 
Use of 2+ products 1,021 19.6 
Frequency of use among users 
(Days used in the past 30 days) 
Median IQRa 
Cigarettes 5 2-20 
Refillable E-cigarettes 3 1-10 
Disposable E-cigarettes 2 1-5.5 
Hookah 2 1-4 
Cigar 2 1-4 
Smokeless 5 1-21 
Depressive Symptoms Median IQRa 
CES-D-10 7 4-11 
a. Interquartile range is the 25th and 75th percentile of the distribution. 
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Table 2. Hierarchical Poisson Model for CES-D-10 Score (Waves 1-6) 
 Rate Ratio
b 95% CI p-value 
Frequency of usec  
[range: 0-6] 
 
 
 
Cigarettes 1.03 1.02-1.04 <.001 
Refillable e-cigarettes 1.01 1.00-1.03 0.02 
Disposable e-cigarettes 1.00 0.98-1.03 0.92 
Hookah 1.03 1.01-1.05 <.01 
Cigars 1.01 0.99-1.04 0.35 
Smokeless 1.00 1.00-1.00 0.92 
Past 30 day used    
Cigarettes 1.04 1.01-1.06 <.01 
Refillable e-cigarettes 1.03 1.00-1.05 0.04 
Disposable e-cigarettes 1.05 0.99-1.11 0.13 
Hookah 1.01 0.99-1.03 0.50 
Cigars 1.02 0.99-1.05 0.14 
Smokeless 1.10 1.04-1.16 <.01 
Frequency of use interactions    
Cigarettes & Refillable e-cigarettes 1.00 0.99-1.00 0.07 
Cigarettes & Disposable e-cigarettes 1.01 1.01-1.02 <.001 
Cigarettes & Cigars 0.99 0.99-1.00 <.05 
Past 30 day use interaction    
Cigarettes & Disposable e-cigarettes 0.88 0.82-0.95 <.01 
 
The model adjusted for socio-demographic covariates (race/ethnicity, sex, baseline age, two- vs. four-
year college, and father’s education) and survey wave. 
b. Rate ratios were calculated using 𝑒𝛽 and represent the multiplicative change in depressive 
symptoms (CES-D-10) associated with a one unit increase in the independent variable. 
c. The number of days of tobacco product use in the past 30 days was scaled so that each one unit 
increase represents an additional 5 days of use. 
d. Past 30 day use was adjusted for frequency of use. Conclusions about the total effect of tobacco 
product use should account for both frequency of use and past 30 day use (see table 3).  
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Table 3. Total Estimated Associations for Tobacco Product Use 
 5 days of use 
in the past 30 days 
15 days of use 
in the past 30 days 
Tobacco Product(s) 
Rate 
Ratio 95% CI 
Rate 
Ratio 95% CI 
Single Product Use     
Cigarettes 1.07 1.04-1.09 1.13 1.10-1.16 
Refillable e-cigarettes 1.04 1.02-1.07 1.07 1.04-1.11 
Disposable e-cigarettes 1.05 0.99-1.11 1.05 0.98-1.13 
Hookah 1.04 1.01-1.06 1.09 1.04-1.15 
Cigars 1.03 1.00-1.07 1.06 0.99-1.14 
  Smokeless 1.10 1.04-1.16 1.10 1.04-1.15 
Dual Use (ATPe = 5 days)     
Cigarettes with refillable  
e-cigarettes = 5 days 
1.11 1.07-1.14 1.16 1.12-1.20 
Cigarettes with disposable  
e-cigarettes = 5 days 
1.00 0.96-1.05 1.09 1.04-1.14 
Cigarettes with  
hookah = 5 days 
1.11 1.07-1.14 1.17 1.13-1.21 
Cigarettes with  
cigars = 5 days 
1.10 1.06-1.13 1.14 1.10-1.18 
Dual Use (Cigarettes = 5 days)     
Refillable e-cigarettes  
with cigarettes = 5 days 
-f  1.13 1.09-1.17 
Disposable e-cigarettes  
with cigarettes = 5 days 
-f  1.03 0.97-1.10 
Hookah  
with cigarettes = 5 days 
-f  1.17 1.11-1.23 
Cigars  
with cigarettes = 5 days 
-f  1.11 1.04-1.18 
 
Estimates are based on the model in table 2 and account for frequency of use, past 30 day use and 
relevant interactions. All associations are adjusted for socio-demographic covariates (race/ethnicity, 
sex, baseline age, two- vs. four-year college, and father’s education) and survey wave. 
e. Alternative Tobacco Product (ATP). 
f. Estimates for dual use of cigarettes and another product (5 days each) are already provided above 
and are not repeated here. 
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APPENDICES 
Appendix A: Bayesian Models 
Bayesian hierarchical Poisson models were used with normally distributed priors for 
each non-varying (“fixed”) coefficient (for helpful overviews of Bayesian statistics see 
McElreath, 2016 or van de Schoot et al., 2014). For main effects, the prior was centered at 0 
with SD=log(1.25). This expresses an expectation of 95% confidence that each independent 
variable would be associated with no more than a 50% increase (or the equivalent decrease 
on the log scale) in depressive symptoms (CES-D-10 score) and that smaller associations are 
more likely than large positive or negative associations. Small changes in CES-D-10 score 
can be practically significant and reflect large changes in overall mental health. Also, the 
maximum score is 30 and the median score is 7. Therefore, we feel it is appropriate to assign 
a small prior probability to very large associations. This approach does not eliminate the 
possibility of large associations, especially since the sample size is large, but these models 
would require more evidence to conclude that associations are large than to conclude that 
associations are small. This is arguably conservative. Importantly, past research would 
suggest the association between depressive symptoms and product use is more likely to be 
positive than negative. Therefore, centering priors for these coefficients at zero should be 
considered conservative for this research question. The priors for interaction effects were 
centered at 0 with SD=log(1.1), expressing an expectation that interaction effects are likely to 
be smaller in magnitude than main effects. The prior for the non-varying intercept was 
centered at the log mean of CES-D-10 with SD=1. Since all continuous independent 
variables (besides frequency of use) were centered at the mean, it seems reasonable to expect 
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the intercept to be close to the mean, however the standard deviation also allows for the 
possibility of very different values. The priors for the other parts of the models are commonly 
used in modern Bayesian analyses (McElreath, 2016): a half-normal prior with SD=1 for the 
standard deviation of the varying intercept and slope, and an LKJ(3) prior for the correlation 
of the varying intercept and slope (Lewandowski, Kurowicka, & Joe, 2009). As a further 
sensitivity analysis, models with priors that were twice as wide and twice as narrow were fit 
to the data (Tables A3 and A4) in addition to the frequentist analysis (Table 2). As is 
common in large samples, Bayesian results were highly similar to the frequentist analysis 
regardless of the priors used.  
The Bayesian models were fit using Markov Chain Monte Carlo (MCMC) in STAN 
(Carpenter et al., 2017). MCMC convergence was examined with trace plots and the Gelman-
Rubin convergence statistic (Gelman & Rubin, 1992). Model fit was assessed graphically 
with posterior predictive check (Figure A1). 
Several models were fit to the data. Model 1 used dichotomous variables for past 30-
day use of each tobacco product. Model 2 considered whether each tobacco product was used 
more than 5 days in the past 30 days, a cutoff suggested in Amato, Boyle and Levy (2016). 
Model 3 included dichotomous variables for past 30-day use and continuous variables for the 
number of days used in the past 30 days. Interaction terms were then added to each of these 
three models for dual use of cigarettes with refillable e-cigarettes, disposable e-cigarettes, 
hookah and cigars, but no interactions were tried for smokeless tobacco, the most rarely used 
product. Of these six models, the model with the interaction terms and continuous frequency 
of use variables (Model 6) best fit the data according to the Widely Applicable Information 
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Criterion (WAIC) (Watanabe, 2010). The final Bayesian model (Table A1) was created by 
removing interaction terms from Model 6 when Pr(𝛽>0)≥0.95 or Pr(𝛽<0)≥0.95 which 
further improved model fit according to WAIC. 
Point and interval estimates are given by the posterior mean and equi-tailed credible 
intervals. Posterior probabilities were calculated for hypotheses of interest. A posterior 
probability is the probability that a hypothesis is true based on the data, the model and the 
priors. Probabilities closer to 1 indicate higher probabilities of the hypothesis being true, 
probabilities of .5 indicate an equal probability of the hypothesis being true or false, and 
probabilities closer to 0 indicate a lower probability of the hypothesis being true (or, 
equivalently, a higher probability of the hypothesis being false).  
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Table A1. Bayesian Hierarchical Poisson Model for CES-D-10 Score 
 Rate Ratio
g 95% CI 
Posterior 
Probabilityh 
(𝛽>0) 
Frequency of usei  
[range: 0-6] 
    
Cigarettes 1.03 1.02 1.04 1.00 
Refillable e-cigarettes 1.01 1.00 1.03 0.99 
Disposable e-cigarettes 1.00 0.98 1.03 0.57 
Hookah 1.03 1.01 1.05 1.00 
Cigars 1.01 0.99 1.04 0.82 
Smokeless 1.00 1.00 1.00 0.46 
Past 30 day usej     
Cigarettes 1.04 1.01 1.06 1.00 
Refillable e-cigarettes 1.03 1.00 1.05 0.98 
Disposable e-cigarettes 1.04 0.98 1.10 0.89 
Hookah 1.01 0.99 1.03 0.76 
Cigars 1.02 0.99 1.05 0.93 
Smokeless 1.09 1.04 1.16 1.00 
Frequency of use interactions     
Cigarettes & Refillable e-cigarettes 1.00 0.99 1.00 0.04 
Cigarettes & Disposable e-cigarettes 1.01 1.01 1.02 >.99 
Cigarettes & Cigars 0.99 0.99 1.00 0.02 
Past 30 day use interaction     
Cigarettes & Disposable e-cigarettes 0.90 0.84 0.96 <.01 
The model adjusted for socio-demographic covariates (race/ethnicity, sex, baseline age, father’s 
education and two- vs. four-year college) and survey wave. 
g. Rate ratios were calculated using 𝑒𝛽 and represent the multiplicative change in depressive 
symptoms (CES-D-10) associated with a one unit increase in the independent variable. 
h. Posterior probabilities here are the probability of a positive association based on the data, the 
model and the priors. The posterior probability of a negative association is 1-Pr(𝛽>0). 
i. The number of days of tobacco product use in the past 30 days was scaled so that each one unit 
increase represents an additional 5 days of use. 
j. Past 30 day use was adjusted for frequency of use. Conclusions about the total effect of tobacco 
product use should account for both frequency of use and past 30 day use (see table 3).  
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Figure A1. Model Goodness of Fit Plot: Cumulative Density with Posterior Predictive Check 
 
Table A2. Candidate Bayesian Hierarchical Poisson Models for CES-D-10 Score 
 Rate Ratio
k 95% CI 
Posterior 
Probability 
(𝛽>0) WAICn 
Model 1     139,997 
Past 30 day use      
Cigarettes 1.06 1.04 1.09 >.99  
Refillable e-cigarettes 1.04 1.02 1.06 >.99  
Disposable e-cigarettes 1.01 0.97 1.04 0.61  
Hookah 1.02 1.00 1.04 0.98  
Cigars 1.03 1.00 1.05 0.98  
Smokeless 1.10 1.05 1.16 >.99  
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Model 2     139,985 
Cigarettes      
0 days Ref     
1-5 days 1.04 1.02 1.07 >.99  
6+ days 1.12 1.09 1.15 >.99  
 
Refillable e-cigarettes 
     
0 days Ref     
1-5 days 1.03 1.01 1.06 0.99  
6+ days 1.06 1.02 1.10 >.99  
Disposable e-cigarettes      
0 days Ref     
1-5 days 0.98 0.94 1.01 0.10  
6+ days 1.07 1.01 1.13 0.99  
Hookah      
0 days Ref     
1-5 days 1.02 1.00 1.04 0.95  
6+ days 1.08 1.03 1.14 >.99  
Cigars      
0 days Ref     
1-5 days 1.03 1.00 1.06 0.98  
6+ days 0.99 0.93 1.05 0.36  
Smokeless      
0 days Ref     
1-5 days 1.10 1.04 1.16 >.99  
6+ days 1.09 1.01 1.17 0.99  
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Model 3     139,975 
Frequency of usel  
[range: 0-6] 
     
Cigarettes 1.03 1.02 1.03 >.99  
Refillable e-cigarettes 1.01 1.00 1.02 0.97  
Disposable e-cigarettes 1.03 1.01 1.05 0.99  
Hookah 1.03 1.01 1.04 >.99  
Cigars 0.99 0.98 1.01 0.28  
Smokeless 1.00 1.00 1.00 0.41  
Past 30 day usem      
Cigarettes 1.03 1.01 1.05 0.99  
Refillable e-cigarettes 1.03 1.00 1.05 0.98  
Disposable e-cigarettes 0.97 0.93 1.01 0.06  
Hookah 1.01 0.99 1.03 0.77  
Cigars 1.03 1.00 1.06 0.96  
Smokeless 1.10 1.04 1.16 >.99  
Model 4     140,007 
Past 30 day use      
Cigarettes 1.07 1.05 1.10 >.99  
Refillable e-cigarettes 1.04 1.01 1.07 >.99  
Disposable e-cigarettes 1.05 0.99 1.10 0.95  
Hookah 1.03 1.00 1.06 0.99  
Cigars 1.02 0.98 1.05 0.80  
Smokeless 1.10 1.05 1.16 >.99  
Past 30 day use interactions      
Cigarettes & Refillable e-cigarettes 1.00 0.96 1.04 0.43  
Cigarettes & Disposable e-cigarettes 0.94 0.88 1.00 0.03  
Cigarettes & Hookah 0.98 0.94 1.02 0.12  
Cigarettes & Cigars 1.02 0.98 1.07 0.82  
Model 5     139,965 
Cigarettes      
0 days Ref     
1-5 days 1.05 1.03 1.08 >.99  
6+ days 1.12 1.08 1.17 >.99  
Refillable e-cigarettes      
0 days Ref     
1-5 days 1.04 1.01 1.08 >.99  
6+ days 1.05 1.00 1.10 0.96  
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Disposable  e-cigarettes 
0 days Ref     
1-5 days 1.02 0.96 1.08 0.75  
6+ days 1.08 0.99 1.17 0.96  
Hookah      
0 days Ref     
1-5 days 1.02 0.99 1.04 0.89  
6+ days 1.14 1.07 1.22 >.99  
Cigars      
0 days Ref     
1-5 days 1.02 0.98 1.05 0.82  
6+ days 1.00 0.92 1.09 0.48  
Smokeless      
0 days Ref     
1-5 days 1.10 1.04 1.16 >.99  
6+ days 1.09 1.01 1.18 0.99  
Interactions      
Cigarettes 1-5 days &  
Refillable e-cigarettes 1-5 days 
0.95 0.90 1.00 0.04 
 
Cigarettes 6+ days &  
Refillable e-cigarettes 1-5 days 
1.00 0.94 1.06 0.47 
 
Cigarettes 1-5 days &  
Refillable e-cigarettes 6+ days 
1.07 1.00 1.15 0.98 
 
Cigarettes 6+ days &  
Refillable e-cigarettes 6+ days 
0.97 0.90 1.04 0.19 
 
Cigarettes 1-5 days &  
Disposable e-cigarettes 1-5 days 
0.97 0.90 1.05 0.25 
 
Cigarettes 6+ days &  
Disposable e-cigarettes 1-5 days 
0.90 0.84 0.98 0.01 
 
Cigarettes 1-5 days &  
Disposable e-cigarettes 6+ days 
0.92 0.82 1.03 0.08 
 
Cigarettes 6+ days &  
Disposable e-cigarettes 6+ days 
1.03 0.93 1.14 0.69 
 
Cigarettes 1-5 days &  
Hookah 1-5 days 
1.01 0.96 1.05 0.62 
 
Cigarettes 6+ days &  
Hookah 1-5 days 
0.99 0.94 1.04 0.35 
 
Cigarettes 1-5 days &  
Hookah 6+ days 
0.85 0.78 0.93 <.01 
 
Cigarettes 6+ days &  
Hookah 6+ days 
0.95 0.87 1.04 0.14 
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Cigarettes 1-5 days &  
Cigars 1-5 days 
1.00 0.94 1.05 0.47 
 
Cigarettes 6+ days &  
Cigars 1-5 days 
1.05 0.99 1.12 0.96 
 
Cigarettes 1-5 days &  
Cigars 6+ days 
1.00 0.90 1.13 0.53 
 
Cigarettes 6+ days &  
Cigars 6+ days 
0.98 0.89 1.09 0.37 
 
Model 6     139,959 
Frequency of usel 
[range: 0-6] 
    
 
Cigarettes 1.03 1.02 1.04 >.99  
Refillable e-cigarettes 1.01 1.00 1.03 0.99  
Disposable e-cigarettes 1.00 0.98 1.03 0.59  
Hookah 1.03 1.01 1.05 >.99  
Cigars 1.01 0.99 1.04 0.84  
Smokeless 1.00 1.00 1.00 0.48  
Past 30 day usem      
Cigarettes 1.04 1.01 1.07 >.99  
Refillable e-cigarettes 1.03 0.99 1.06 0.94  
Disposable e-cigarettes 1.04 0.98 1.10 0.88  
Hookah 1.02 0.99 1.04 0.87  
Cigars 1.01 0.97 1.05 0.63  
Smokeless 1.09 1.04 1.16 >.99  
Frequency of use interactions      
Cigarettes & Refillable e-cigarettes 1.00 0.99 1.00 0.04  
Cigarettes & Disposable e-cigarettes 1.01 1.01 1.02 >.99  
Cigarettes & Hookah 1.00 0.99 1.01 0.39  
Cigarettes & Cigars 0.99 0.99 1.00 0.02  
Past 30 day use interactions      
Cigarettes & Refillable e-cigarettes 1.00 0.96 1.05 0.56  
Cigarettes & Disposable e-cigarettes 0.90 0.84 0.96 <.01  
Cigarettes & Hookah 0.98 0.94 1.02 0.13  
Cigarettes & Cigars 1.03 0.98 1.08 0.86  
 
All models adjusted for socio-demographic covariates (race/ethnicity, sex, baseline age, two- vs. four-
year college and father’s education) and survey wave. 
k. Rate ratios were calculated using 𝑒𝛽 and represent the multiplicative change in depressive 
symptoms (CES-D-10) associated with a one unit increase in the independent variable. 
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l. The number of days of tobacco product use in the past 30 days was scaled so that each one unit 
increase represents an additional 5 days of use. 
m. In models 3 and 6, past 30 day use was adjusted for frequency of use. Conclusions about the total 
effect of tobacco product use should account for both frequency of use and past 30 day use. 
n. Widely Applicable Information Criterion for the final model (in table A1) is 139,947. 
 
Table A3. Bayesian Hierarchical Poisson Models with Different Priors 
 Rate Ratio 95% CI 
Posterior 
Probability 
(𝛽>0) 
Table A1 Model (Wider Priors)     
Frequency of use  
[range: 0-6] 
    
Cigarettes 1.03 1.02 1.04 >.99 
Refillable e-cigarettes 1.01 1.00 1.03 0.99 
Disposable e-cigarettes 1.00 0.98 1.03 0.54 
Hookah 1.03 1.01 1.05 >.99 
Cigars 1.01 0.99 1.04 0.81 
Smokeless 1.00 1.00 1.00 0.46 
Past 30 day use     
Cigarettes 1.04 1.01 1.06 >.99 
Refillable e-cigarettes 1.03 1.00 1.05 0.98 
Disposable e-cigarettes 1.05 0.99 1.11 0.93 
Hookah 1.01 0.98 1.03 0.76 
Cigars 1.02 0.99 1.05 0.94 
Smokeless 1.10 1.04 1.16 >.99 
Frequency of use interactions     
Cigarettes & Refillable e-cigarettes 1.00 0.99 1.00 0.03 
Cigarettes & Disposable e-cigarettes 1.01 1.01 1.02 >.99 
Cigarettes & Cigars 0.99 0.99 1.00 0.04 
Past 30 day use interaction     
Cigarettes & Disposable e-cigarettes 0.89 0.83 0.95 <.01 
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Table A1 Model (Narrower Priors) 
Frequency of use  
[range: 0-6] 
    
Cigarettes 1.03 1.02 1.04 >.99 
Refillable e-cigarettes 1.01 1.00 1.03 0.99 
Disposable e-cigarettes 1.00 0.98 1.03 0.65 
Hookah 1.03 1.01 1.05 >.99 
Cigars 1.01 0.99 1.04 0.81 
Smokeless 1.00 1.00 1.00 0.50 
Past 30 day use     
Cigarettes 1.03 1.01 1.06 >.99 
Refillable e-cigarettes 1.03 1.00 1.05 0.98 
Disposable e-cigarettes 1.02 0.97 1.08 0.74 
Hookah 1.01 0.99 1.03 0.76 
Cigars 1.02 0.99 1.05 0.93 
Smokeless 1.09 1.03 1.15 >.99 
Frequency of use interactions     
Cigarettes & Refillable e-cigarettes 1.00 0.99 1.00 0.03 
Cigarettes & Disposable e-cigarettes 1.01 1.01 1.02 >.99 
Cigarettes & Cigars 0.99 0.99 1.00 0.04 
Past 30 day use interaction     
Cigarettes & Disposable e-cigarettes 0.89 0.83 0.95 <.01 
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Table A2 Model 6 (Wider Priors) 
Frequency of use  
[range: 0-6] 
    
Cigarettes 1.03 1.02 1.04 >.99 
Refillable e-cigarettes 1.01 1.00 1.03 0.99 
Disposable e-cigarettes 1.00 0.98 1.03 0.53 
Hookah 1.03 1.01 1.05 >.99 
Cigars 1.01 0.99 1.04 0.86 
Smokeless 1.00 1.00 1.00 0.48 
Past 30 day use     
Cigarettes 1.04 1.01 1.07 0.99 
Refillable e-cigarettes 1.02 0.99 1.06 0.92 
Disposable e-cigarettes 1.05 0.98 1.11 0.91 
Hookah 1.02 0.99 1.04 0.86 
Cigars 1.00 0.97 1.04 0.57 
Smokeless 1.10 1.03 1.16 >.99 
Frequency of use interactions     
Cigarettes & Refillable e-cigarettes 1.00 0.99 1.00 0.03 
Cigarettes & Disposable e-cigarettes 1.01 1.01 1.02 >.99 
Cigarettes & Hookah 1.00 0.99 1.01 0.41 
Cigarettes & Cigars 0.99 0.99 1.00 0.02 
Past 30 day use interaction     
Cigarettes & Refillable e-cigarettes 1.01 0.96 1.05 0.59 
Cigarettes & Disposable e-cigarettes 0.89 0.83 0.96 <.01 
Cigarettes & Hookah 0.98 0.94 1.02 0.15 
Cigarettes & Cigars 1.03 0.98 1.08 0.89 
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Table A2 Model 6 (Narrower Priors) 
Frequency of use  
[range: 0-6] 
    
Cigarettes 1.03 1.02 1.04 >.99 
Refillable e-cigarettes 1.01 1.00 1.03 0.99 
Disposable e-cigarettes 1.00 0.98 1.03 0.65 
Hookah 1.03 1.01 1.05 >.99 
Cigars 1.01 0.99 1.04 0.82 
Smokeless 1.00 1.00 1.00 0.48 
Past 30 day use     
Cigarettes 1.04 1.01 1.06 >.99 
Refillable e-cigarettes 1.03 0.99 1.06 0.95 
Disposable e-cigarettes 1.02 0.96 1.07 0.73 
Hookah 1.02 0.99 1.04 0.88 
Cigars 1.01 0.97 1.05 0.71 
Smokeless 1.09 1.04 1.15 >.99 
Frequency of use interactions     
Cigarettes & Refillable e-cigarettes 1.00 0.99 1.00 0.04 
Cigarettes & Disposable e-cigarettes 1.01 1.00 1.02 >.99 
Cigarettes & Hookah 1.00 0.99 1.01 0.40 
Cigarettes & Cigars 0.99 0.99 1.00 0.03 
Past 30 day use interaction     
Cigarettes & Refillable e-cigarettes 1.00 0.96 1.04 0.52 
Cigarettes & Disposable e-cigarettes 0.93 0.88 0.98 <.01 
Cigarettes & Hookah 0.98 0.95 1.02 0.13 
Cigarettes & Cigars 1.02 0.98 1.07 0.85 
 
Table A4. Priors Used for Models in Table A3 
Model Parameter(s) Wider Priors Narrower Priors 
Main effects Normal(0, 0.4462) Normal(0, 0.11155) 
Interaction terms Normal(0, 0.1906) Normal(0, 0.04765) 
Intercept Normal(2.0689, 2) Normal(2.0689, .5) 
Varying Intercept & Slope (SD) Half-normal(2) Half-normal(.5) 
Correlation of Varying Intercept & Slope LKJ(1.5) LKJ(6) 
 
